ReviewCancers2020

Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers.

Xabier Mielgo-Rubio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.